Deletion of mitochondrial calcium uniporter incompletely inhibits calcium uptake and induction of the permeability transition pore in brain mitochondria

J Biol Chem. 2018 Oct 5;293(40):15652-15663. doi: 10.1074/jbc.RA118.002926. Epub 2018 Aug 28.

Abstract

Ca2+ influx into mitochondria is mediated by the mitochondrial calcium uniporter (MCU), whose identity was recently revealed as a 40-kDa protein that along with other proteins forms the mitochondrial Ca2+ uptake machinery. The MCU is a Ca2+-conducting channel spanning the inner mitochondrial membrane. Here, deletion of the MCU completely inhibited Ca2+ uptake in liver, heart, and skeletal muscle mitochondria. However, in brain nonsynaptic and synaptic mitochondria from neuronal somata/glial cells and nerve terminals, respectively, the MCU deletion slowed, but did not completely block, Ca2+ uptake. Under resting conditions, brain MCU-KO mitochondria remained polarized, and in brain MCU-KO mitochondria, the electrophoretic Ca2+ ionophore ETH129 significantly accelerated Ca2+ uptake. The residual Ca2+ uptake in brain MCU-KO mitochondria was insensitive to inhibitors of mitochondrial Na+/Ca2+ exchanger and ryanodine receptor (CGP37157 and dantrolene, respectively), but was blocked by the MCU inhibitor Ru360. Respiration of WT and MCU-KO brain mitochondria was similar except that for mitochondria that oxidized pyruvate and malate, Ca2+ more strongly inhibited respiration in WT than in MCU-KO mitochondria. Of note, the MCU deletion significantly attenuated but did not completely prevent induction of the permeability transition pore (PTP) in brain mitochondria. Expression level of cyclophilin D and ATP content in mitochondria, two factors that modulate PTP induction, were unaffected by MCU-KO, whereas ADP was lower in MCU-KO than in WT brain mitochondria. Our results suggest the presence of an MCU-independent Ca2+ uptake pathway in brain mitochondria that mediates residual Ca2+ influx and induction of PTP in a fraction of the mitochondrial population.

Keywords: calcium; cyclophilin D; energy metabolism; ion channel; mitochondria; mitochondrial membrane potential; mitochondrial permeability transition (MPT); respiration.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / drug effects
  • Brain / metabolism*
  • Calcium / metabolism*
  • Calcium Channels / deficiency
  • Calcium Channels / genetics*
  • Cyclohexanes / pharmacology
  • Dantrolene / pharmacology
  • Female
  • Gene Deletion
  • Ion Transport / drug effects
  • Ionophores / pharmacology
  • Malates / metabolism
  • Malates / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Mitochondria, Heart / drug effects
  • Mitochondria, Heart / metabolism
  • Mitochondria, Liver / drug effects
  • Mitochondria, Liver / metabolism
  • Mitochondrial Membrane Transport Proteins / genetics*
  • Mitochondrial Membrane Transport Proteins / metabolism
  • Mitochondrial Permeability Transition Pore
  • Neurons / drug effects
  • Neurons / metabolism*
  • Pyruvic Acid / metabolism
  • Pyruvic Acid / pharmacology
  • Ruthenium Compounds / pharmacology
  • Thiazepines / pharmacology

Substances

  • 7-chloro-5-(2-isopropylphenyl)-3,5-dihydro-4,1-benzothiazepin-2-(1H)-one
  • Calcium Channels
  • Cyclohexanes
  • Ionophores
  • Malates
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Ru 360
  • Ruthenium Compounds
  • Thiazepines
  • mitochondrial calcium uniporter
  • N,N,N',N'-tetracyclohexyl-3-oxapentanediamide
  • malic acid
  • Pyruvic Acid
  • Dantrolene
  • Calcium